A packaged medical device comprising a medical device; a gas-permeable sterile bag containing the medical device therein; a wrapping member made of oxygen-impermeable material and wherein said medical device-containing bag, previously subjected to radiation-sterilization, is sealed; and a deoxidizing agent contained in the wrapping member together with the medical device-containing bag. The packaged medical device does not give off an odor upon unsealing and is free from decrease in strength of plastic parts thereof.
|
1. A process for producing a radiation-sterilized medical device comprising the steps of:
placing a medical device within a gas-permeable sterile bag; sealing said gas-permeable sterile bag; sterilizing said gas-permeable sterile bag containing said medical device by gamma rays; placing said sterilized gas-permeable bag containing said medical device and also placing a deoxidizing agent within an oxygen impermeable wrapping member; and sealing said oxygen-impermeable wrapping member.
2. A process of producing a radiation-sterilized medical device according to
3. A process of producing a radiation-sterilized medical device according to
4. A process of producing a radiation-sterilized medical device according to
5. A process of producing a radiation-sterilized medical device according to
6. A process of producing a radiation-sterilized medical device according to
7. A process of producing a radiation-sterilized medical device according to
8. A process of producing a radiation-sterilized medical device according to
9. A process of producing a radiation-sterilized medical device according to
|
This application is a division of application Ser. No. 854,354 filed Apr. 21, 1986 and now abandoned.
The present invention relates to a radiation-sterilized medical device. More particularly, the present invention relates to a packaged medical device provided with a deodorizing means adapted to prevent emanation of an odor upon withdrawal of a radiation-sterilized medical device from a sterile containment bag.
As a method for sterilizing medical devices, sterilization with gamma-rays has been widely employed in recent years, particularly in the field of disposable medical devices. In order to maintain sterility up till the time of use, such a disposable medical device is generally sealed in a sterile bag and then sterilized with gamma-rays as pre-packaged in the bag. However, because of the presence of oxygen in the bag, irradiation with gamma-rays or other radiation excites the oxygen to yield ozone, an allotrope of oxygen, and, hence, generates the so-called gamma odor which is considered to be associated with ozone. This odor emanating upon unsealing of the sterile bag for removal of the medical device therefrom gives an uncomfortable sensation to the user of the device.
Furthermore, disposable medical devices are made, for the most part, of some plastic material or other and may suffer from decreased strength due to oxidation with time. Particularly in dry radiation-sterilization in a gaseous atmosphere where the surface of the plastic material is exposed to air, the presence of radiation-excited oxygen promotes oxidation of the plastic material with time at elevated temperature so as to induce a decrease in strength.
In view of the problems mentioned hereinbefore, the present inventors conducted an intensive research and discovered that these problems all spring out from the presence of oxygen. Accordingly, they sought for means for elimination of oxygen.
The object of the present invention is to provide a dry radiation-sterilized medical equipment which does not give off an odor upon unsealing and is free from decreases in the strength of plastic parts thereof.
This and other objects of the invention will become apparent from the description hereinafter.
The present invention provides a packaged medical device comprising a medical device; a gas-permeable sterile bag containing the medical device therein; a wrapping member made of oxygen-impermeable material and wherein said madical device-containing bag, previously subjected to radiation-sterilization, is sealed; and deoxidizing agent contained in the wrapping . member together with the medical device-containing bag.
FIG. 1 is a schematic illustration showing a packaged medical device in accordance with the present invention.
In the present invention, the radiation-sterilization is preferably sterilization with gamma-rays and the deoxidizing agent is preferably one based on activated iron oxide. The medical device to which the present invention can be applied with advantage includes a hollow fiber blood processing device, particularly a blood processing device employing a cellulose acetate hollow fiber membrane, which is generally believed to be incompatible with dry radiation-sterilization. The oxygen-impermeable material is preferably a laminated polyester-aluminum-polyethylene sheet.
According to the present invention, a medical device sealed in a sterile bag, after radiation-sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent. For the reason, there is substantially no infiltration of oxygen from external environments and even the oxygen trapped in the course of the wrapping step is absorbed by the co-existing deoxidizing agent. Therefore, the inside of the wrapping member can be maintained in anoxic state so that the emanation of an odor and aging of the strength of the medical device can be successfully prevented.
Furthermore, since the sterile bag is a gas-permeable sterile bag, the oxygen and ozone present in the bag and the oxygen gradually released from the medical device are also instantly absorbed.
In addition, since the wrapping member is made of an oxygen-impermeable material, the entry of oxygen from the external environment is prevented almost completely and, therefore, an oxygen-free condition within the wrapping member can be maintained for a long time period.
An preferred embodiment of the present invention will now be described with reference to the accompanying drawing.
Referring to FIG. 1, a packaged medical device according to the present invention comprises a medical. device 1 such as hollow fiber blood processing device, as sealed in a sterile bag 2 and further hermetically sealed, together with a deoxidizing agent 3, in a wrapping member 4. That is, the medical device 1 as such is first sealed in the sterile bag 2 and, then, after sterilization with gamma-rays, hermetically sealed into the wrapping member 4 together with the deoxidizing agent 3.
The sterile bag 2 is a gas-permeable sterile bag and the wrapping member 4 is made of an oxygen impermeable material. The reason for using such a gas-permeable bag as the sterile bag is that if a gas-impermeable sterile bag be employed, even if sealing is made under oxygen-free conditions, the oxygen inherent in the medical device itself is gradually released and collects within the sterile bag and, as experience tells, the decrease in strength of the medical device is accelerated at elevated temperature.
In the invention, the term "sterile bag" is intended to mean a bag which is subjected to sterilization treatment in a state that a medical device is contained therein and through the wall of which bacteria cannot pass. The sterile bag may be gas-permeable over the entire surfaces thereof or in a part thereof.
Examples of the sterile bag include the followings: (1) A bag, both sides of which are made of a laminated polyester-polyethylene film and which has one or more gas-permeable parts where one or more openings such as slit are provided in the laminated film and the opening portions are covered with a polyethylene non-woven fabric or a wood-free paper. (2) A bag, one side of which is made of a wood-free paper or a polyethylene non-woven fabric, and the other side of which is made of a laminated polyester-polyethylene film. (3) A bag, both sides of which are made of a wood-free paper or a polyethylene non-woven fabric.
The reason for using a wrapping member made of an oxygen-impermeable material is to prevent infiltration of oxygen from external environments and, hence, to ensure a long efficacy life of the deoxidizing agent. Examples of the wrapping member used in the invention include a laminated sheet consisting of an exterior polyester film, an intermediate aluminum foil (or aluminum deposition layer) and an inner polyethylene film, a laminated sheet consisting of an exterior polyester film, an intermediate polyethylene film, an intermediate aluminum foil (or aluminum deposition layer) and an inner polyethylene film, a laminated sheet consisting of an exterior biaxially orientated polypropylene film, an intermediate ethylene-vinyl alcohol copolymer film and an inner polyethylene film, a laminated sheet consisting of an exterior vinylon film having a polyvinylidene chloride coating on both sides thereof and an inner polyethylene film, a laminated sheet consisting of an exterior biaxially orientated polyvinyl alcohol film and an inner polyethylene film, a laminated sheet consisting of an exterior polyvinylidene chloride-coated orientated polypropylene film and an inner polyethylene film, a laminated sheet consisting of an exterior polyvinylidene chloride-coated polyester film and an inner polyethylene film, a laminated sheet consisting of an exterior polyvinylidene chloride-coated oriented nylon film and an inner polyethylene film, a laminated sheet consisting of an exterior polyvinylidene chloride-coated cellophane and an inner polyethylene film, and a laminated sheet consisting of an exterior laminated high impact polystyrene-polyvinylidene chloride-polyethylene film and an inner non-oriented polypropylene film. From the standpoint of cost and efficiency, the most preferred examples of the oxygen-impermeable materials are a laminated sheet consisting of an exterior polyester film, an intermediate aluminum foil (or aluminum deposition layer) and an inner polyethylene film, and a laminated sheet consisting of an exterior polyester film, an intermediate polyethylene film, an intermediate aluminum foil (or aluminum deposition layer) and an inner polyethylene film.
The sterilization method may be any radiation-sterilization method, including one using gamma-rays and one utilizing electron beams. However, the present invention is more effective in case of sterilization with gamma-rays, which has a greater influence on the strength of the medical device, since the effect of the present invention which comprises sealing a medical device in an oxygen-impermeable wrapping member together with a deoxidizing agent is noticeably exhibited, especially when the problem of decreased strength of the medical device due to radiation-excited oxygen is taken into consideration.
The absorbed dose used in the radiation-sterilization sterilization varies depending upon the kind of medical device and the kind of radiation. In the case of sterilization of hollow fiber blood processing device with gamma-rays, an absorbed dose of 1.8 to 2.5 Mrad is usually used.
Because the deoxidizing agent is sealed together with a medical device contained in a gas-permeable sterile bag, it must be non-toxic. Moreover, the deoxidizing agent is preferably one which does not give rise to gases (hydrogen gas, carbon dioxide gas, and the like) upon absorption of oxygen. For these reasons, the deoxidizing agent is desirably one based on an active metal or metal compound and having its reaction rate, etc. controlled by a catalyst. The active metal or metal compound may for example be iron, zinc, copper or tin, or oxides of the foregoing metal but among the currently available deoxidizing agents, those based on activated iron oxide are most desirable. Among commercial deoxidizing agents of this type is Ageless (a commercial name of Mitsubishi Gas Chemical Company, Inc.). The deoxidizing agent is contained in a gas-permeable bag or container.
In the present invention, it is essential that, the medical device-containing bag is previously sterilized and then sealed together with a deoxidizing agent in an oxygen-impermeable wrapping member. That is, it must be avoided that a medical device is sealed together with a deoxidizing agent in a gas-impermeable bag and is subjected to radiation-sterilization in a state that the deoxidizing agent is present in the bag. The reason therefor is that when the medical device-containing bag is subjected to radiation sterilization in a state that a deoxidizing agent is present in the bag, the D value (which means the absorbed dose in which the number of bacteria is reduced to one-tenth time that before irradiation) is increased. This tendency is marked particularly in the case of a medical device using cellulose acetate hollow fiber, as shown in Example 4. The tendency is also observed in the case of a medical device using silicone rubber hollow fiber.
As a method for removing the odor generated within the sterile bag, it might be contemplated to seal active carbon as a deodorant together with the medical device but in view of the fact that this material occupies more than 10 times the volume of a typical deoxidizing agent, that its deodorizing efficiency is poor at elevated temperature, and that it does not prevent the decrease of strength with time, for instance, the use of active carbon is not suitable for the purposes of the present invention.
Referring to the medical device to be packed according to the present invention, the method for inhibiting decrease of strength in accordance with the present invention, that is a method comprising sealing a medical device contained in a gas-permeable sterile bag in an oxygen-impermeable wrapping member together with a deoxidizing agent after radiation-sterilization, can be applied to the radiation-sterilization of any medical device basically made of a plastic material. For example, the present invention is of course effective for a medical device such that its loss of strength will be confined within a tolerable range even without provision of any specific means for preventing such decrease of strength. However, from the standpoint of cost and efficiency, the present invention can be preferably applied to hollow fiber blood processing devices, particularly to blood processing devices employing cellulose acetate hollow fiber membranes. Typical example of hollow fiber blood processing devices includes dialyzer for artificial kidney. The present invention is also preferably applied to artificial lung employing silicone rubber hollow fiber membranes and to catheter made of silicone rubber.
The present invention is more specifically described and explained by means of the following Examples. It is to be understood that the present invention is not limited to the Examples, and various change and modifications may be made in the invention without departing from the spirit and scope thereof.
A dialyzer containing a bundle of 8,800 cellulose acetate hollow fibers each having an effective length of 20 cm, an outer diameter of 230 μm and an inner diameter of 200 μm was placed in a gas-permeable sterile bag, both sides of which was made of a laminated polyester-polyethylene film and which had a slit on the one side thereof with the slit portion being covered with a polyethylene non-woven fabric, and the bag was sealed. The bag containing the dialyzer was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The sterilized bag was inserted together with 10 g of Ageless as a deoxidizing agent into a wrapping member in the form of bag and made from a laminated sheet consisting of a polyester film having a thickness of 12 μm, an aluminum foil having a thickness of 9 μm and a polyethylene film having a thickness of 40 μm, which layers were laminated in that order, and the wrapping member was heat-sealed.
The deodorizing effect was determined at appropriate time intervals. The results are shown in Table 1. In Table 1, 1W, 2W and 4W represent the storage periods of 1, 2 and 4 weeks, respectively. The symbols in Table 1 mean the followings:
No odor is detected.
Odor is detected.
The same procedures as in Example 1 were repeated except that a laminated sheet consisting of a polyester film having a thickness of 12 μm, a polyethylene film having a thickness of 15 μm, an aluminum foil having a thickness of 9 μm and a polyethylene film having a thickness of 40 μm, which layers were laminated in that order, was used as a wrapping member.
The results are shown in Table 1.
The same procedures as in Example 1 were repeated except that 50 g of an active carbon was used instead of Ageless (Comparative Example 1) or both Ageless and the active carbon were not used (Comparative Example 2).
The results are shown in Table 1.
TABLE 1 |
______________________________________ |
Storage |
condition Blank |
Temp. (no irra- |
Irradiation (2.5 Mrad) |
(°C.) |
period diation Ex. 1 |
Ex. 2 |
Com. Ex. 1 |
Com. Ex. 2 |
______________________________________ |
40 1 W ○ ○ |
○ |
○ |
X |
2 W ○ ○ |
○ |
○ |
X |
4 W ○ ○ |
○ |
X X |
50 1 W ○ ○ |
○ |
○ |
X |
2 W ○ ○ |
○ |
X X |
4 W ○ ○ |
○ |
X X |
60 1 W ○ ○ |
○ |
X X |
2 W ○ ○ |
○ |
X X |
4 W ○ ○ |
○ |
X X |
______________________________________ |
The results of Table 1 reveal that the use of a deoxidizing agent produces a noticeable deodorizing effect.
The same hollow fiber as used in Example 1 was sterilized and packaged in the same manner as in Example 1. The aging of the strength of the follow fiber was determined. The results are shown in Table 2. In Table 2, each strength value is expressed in terms of an average value + standard deviation for ten hollow fibers.
The same procedures as in Example 3 were repeated except that no deoxidizing agent was used. The results are shown in Table 2.
TABLE 2 |
__________________________________________________________________________ |
Blank Irradiation (2.5 Mrad) |
(No irradiation) |
Ex. 3 Com. Ex. 3 |
Storage Tensile Tensile Tensile |
condition |
strength |
Elongation |
strength |
Elongation |
strength |
Elongation |
Temp. at breaking |
at breaking |
at breaking |
at breaking |
at breaking |
at breaking |
(°C.) |
Period |
(g/fiber) |
(%) (g/fiber) |
(%) (g/fiber) |
(%) |
__________________________________________________________________________ |
40 1 W 76 ± 13 |
80 ± 11 |
76 ± 10 |
82 ± 13 |
75 ± 6 |
81 ± 12 |
2 W 78 ± 10 |
81 ± 10 |
77 ± 8 |
79 ± 8 |
61 ± 8 |
73 ± 10 |
4 W 77 ± 11 |
79 ± 12 |
77 ± 10 |
80 ± 10 |
55 ± 7 |
72 ± 14 |
50 1 W 78 ± 12 |
80 ± 10 |
77 ± 8 |
80 ± 12 |
70 ± 5 |
75 ± 8 |
2 W 77 ± 11 |
79 ± 13 |
78 ± 6 |
81 ± 10 |
58 ± 7 |
72 ± 13 |
4 W 79 ± 10 |
79 ± 7 |
76 ± 10 |
79 ± 12 |
49 ± 8 |
70 ± 10 |
60 1 W 78 ± 12 |
80 ± 10 |
76 ± 12 |
79 ± 9 |
58 ± 7 |
73 ± 8 |
2 W 76 ± 10 |
80 ± 6 |
76 ± 8 |
80 ± 12 |
42 ± 5 |
67 ± 10 |
4 W 77 ± 15 |
79 ± 11 |
75 ± 10 |
79 ± 8 |
31 ± 6 |
50 ± 12 |
__________________________________________________________________________ |
The results of Table 2 reveal that the use of a deoxidizing agent contributes remarkably to prevention of decrease in strength due to aging from the hollow fiber.
The same dialyzer as used in Example 1 was placed in the same sterile bag as used in the Example 1 and gamma-rays were irradiated thereto. The D value was determined with respect to Bacillus pumilus ATCC 27142. The results are shown in Table 3.
The same procedures as in the above were repeated with a dialyzer using polypropylene hollow fibers or an artificial lung using silicone rubber hollow fibers. The results are also shown in Table 3.
The same procedures as in Example 4 were repeated except that each medical device was placed together with Ageless in the same oxygen-impermeable wrapping member as used in Example 1 and then subjected to irradiation of gamma-rays. The results are shown in Table 3.
TABLE 3 |
______________________________________ |
D value (Mrad) |
Hollow fiber Ex. 4 Com. Ex. 4 |
______________________________________ |
Cellulose acetate |
0.213 0.405 |
Polypropylene 0.197 0.210 |
Silicone rubber 0.167 0.258 |
______________________________________ |
Results of Table 3 reveal that the irradiation of gamma-rays in the presence of a dioxidizing agent invites a great increase in the D value, particularly in the case of cellulose acetate hollow fiber. Therefore, it is desirable that the irradiation of gamma-rays is carried out in the absence of a dioxidizing agent.
In addition to the elements and ingredients used in the Examples, other elements and ingredients can be used in the Examples as set forth in the specification to obtain substantially the same results.
It will be apparent from the foregoing description that since the present invention comprises sealing a medical device contained in a gas-permeable sterile bag further in an oxygen-impermeable wrapping member together with a deoxidizing agent, it eliminates the oxygen from the wrapping member as well as from the sterile bag and even disposes of the oxygen emanating gradually from the medical device as well.
Furthermore, since the wrapping member is made of an oxygen-impermeable material, there is substantially no entry of external oxygen so that the deoxidizing agent may retain its function for an extended time period.
Masuda, Toshiaki, Fukui, Kiyoshi, Omiya, Hitoshi
Patent | Priority | Assignee | Title |
10004857, | Aug 09 2013 | Boehringer Ingelheim International GmbH | Nebulizer |
10011906, | Mar 31 2009 | Boehringer Ingelheim International GmbH | Method for coating a surface of a component |
10016465, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cured gel and method of making |
10016568, | Nov 25 2009 | Boehringer Ingelheim International GmbH | Nebulizer |
10080620, | Feb 06 2012 | Hyprotek, Inc. | Portable medical device protectors |
10099022, | May 07 2014 | Boehringer Ingelheim International GmbH | Nebulizer |
10124125, | Nov 25 2009 | Boehringer Ingelheim International GmbH | Nebulizer |
10124129, | Jan 02 2008 | Boehringer Ingelheim International GmbH | Dispensing device, storage device and method for dispensing a formulation |
10137234, | Oct 15 2004 | Nipro Corporation | Method for sterilizing blood purifier and blood purifier package |
10195374, | May 07 2014 | Boehringer Ingelheim International GmbH | Container, nebulizer and use |
10220163, | Apr 13 2012 | Boehringer Ingelheim International GmbH | Nebuliser with coding means |
10278729, | Apr 26 2013 | Medtronic Xomed, Inc | Medical device and its construction |
10285964, | Mar 10 2009 | ATRIUM MEDICAL CORPORATION | Fatty-acid based particles |
10322213, | Jul 16 2010 | ATRIUM MEDICAL CORPORATION | Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
10377520, | Dec 05 2013 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
10492868, | Jan 28 2011 | Medtronic Navigation, Inc.; Medtronic Navigation, Inc | Method and apparatus for image-based navigation |
10507319, | Jan 09 2015 | Bayer HealthCare LLC | Multiple fluid delivery system with multi-use disposable set and features thereof |
10568699, | Mar 10 2009 | Medtronic Xomed, Inc. | Navigating a surgical instrument |
10610593, | Jun 13 2012 | ATRIUM MEDICAL CORPORATION | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
10617374, | Jan 28 2011 | Medtronic Navigation, Inc.; Medtronic Navigation, Inc | Method and apparatus for image-based navigation |
10617472, | Feb 06 2012 | HYPROTEK, INC | Adhesive patch with antimicrobial composition |
10716905, | Feb 23 2014 | Boehringer lngelheim International GmbH | Container, nebulizer and use |
10722666, | May 07 2014 | Boehringer Ingelheim International GmbH | Nebulizer with axially movable and lockable container and indicator |
10772995, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
10792312, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Barrier layer |
10793327, | Oct 09 2017 | Terumo BCT Biotechnologies, LLC | Lyophilization container and method of using same |
10806665, | Jan 18 2016 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
10814043, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
10864304, | Aug 11 2009 | ATRIUM MEDICAL CORPORATION | Anti-infective antimicrobial-containing biomaterials |
10869902, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cured gel and method of making |
10882654, | Dec 05 2013 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
10888617, | Jun 13 2012 | ATRIUM MEDICAL CORPORATION | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
10894134, | Aug 09 2013 | Boehringer Ingelheim International GmbH | Nebulizer |
10945959, | Mar 07 2019 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
11083823, | Sep 28 2005 | ATRIUM MEDICAL CORPORATION | Tissue-separating fatty acid adhesion barrier |
11097035, | Jul 16 2010 | ATRIUM MEDICAL CORPORATION | Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
11166929, | Mar 10 2009 | ATRIUM MEDICAL CORPORATION | Fatty-acid based particles |
11279510, | Dec 05 2013 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
11460248, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Lyophilization container fill fixture, system and method of use |
11491318, | Jan 09 2015 | Bayer HealthCare LLC | Multiple fluid delivery system with multi-use disposable set and features thereof |
11604026, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Lyophilization loading tray assembly and system |
11609042, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Multi-part lyophilization container and method of use |
11609043, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Lyophilization container fill fixture, system and method of use |
11634257, | Oct 09 2017 | Terumo BCT Biotechnologies, LLC | Lyophilization container and method of using same |
11642476, | Aug 09 2013 | Boehringer Ingelheim International GmbH | Nebulizer |
11740019, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Lyophilization loading tray assembly and system |
11747082, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Multi-part lyophilization container and method of use |
11793912, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
11815311, | Mar 14 2019 | Terumo BCT Biotechnologies, LLC | Lyophilization container fill fixture, system and method of use |
11883063, | Apr 26 2013 | Medtronic Xomed, Inc. | Medical device and its construction |
4941308, | Jul 25 1988 | Abbott Laboratories | Method of packaging for a sterilizable calibratable medical device |
4998400, | Dec 29 1987 | Material Engineering Technology Laboratory, Incorporated | Medical fluid-filled plastic container and methods of making same |
5014494, | Sep 27 1988 | Sherwood Services AG; TYCO GROUP S A R L | Method of sterilizing medical articles |
5447011, | Oct 07 1992 | Kabi Pharmacia GmbH | Product with reduced H2 S content and a process of making the same |
5449745, | Jun 01 1993 | Stryker Technologies Corporation | Non-oxidizing polymeric medical implant |
5540033, | Jan 10 1994 | Cambrex Hydrogels | Integrated Manufacturing process for hydrogels |
5645608, | Jan 03 1996 | CYCLO3PSS CORPORATION | Cold water wash method |
5650485, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non-oxidizing polymeric medical implant |
5658466, | Mar 16 1994 | Teijin Limited | Method of sterilizing a blood dialyzer having semipermeable polymeric membranes by γ-ray irradiation |
5728748, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non oxidizing polymeric medical implant |
5763382, | Jan 03 1996 | TOLAND, ROGER T | Cold water wash formula |
5863496, | Nov 25 1996 | Biomerieux, Inc | Sterile packaging |
5868245, | May 15 1996 | Intermedics, Inc. | Antiseptic disposables and methods for medical and surgical procedures |
5879620, | Nov 13 1997 | CITIBANK, N A | Sterilization wrap and procedures |
5910138, | Apr 11 1997 | B BRAUN MEDICAL, INC | Flexible medical container with selectively enlargeable compartments and method for making same |
5928213, | Apr 11 1997 | B BRAUN MEDICAL, INC | Flexible multiple compartment medical container with preferentially rupturable seals |
5944709, | May 13 1996 | B BRAUN MEDICAL, INC PA CORPORATION | Flexible, multiple-compartment drug container and method of making and using same |
6006387, | Nov 30 1995 | CYCLO3PSS CORPORATION | Cold water ozone disinfection |
6029422, | May 15 1996 | ADVANCED MEDICAL DEVICES, S A | Antiseptic disposables and methods for medical and surgical procedures |
6062390, | Jun 12 1997 | Brother Kogyo Kabushiki Kaisha | Package for recording head unit, method for packaging the same, and combination of package and recording head unit of ink-jet recording apparatus |
6115862, | Nov 30 1995 | Cyclo3PSS Textile Systems, Inc. | Cold water ozone disinfection |
6165161, | May 13 1996 | B. Braun Medical, Inc. | Sacrificial port for filling flexible, multiple-compartment drug container |
6165207, | May 27 1999 | ZOLL CIRCULATION, INC | Method of selectively shaping hollow fibers of heat exchange catheter |
6174934, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non-oxidizing polymeric medical implant |
6198106, | May 13 1996 | B. Braun Medical, Inc. | Transport and sterilization carrier for flexible, multiple compartment drug container |
6203535, | May 13 1996 | B. Braun Medical, Inc. | Method of making and using a flexible, multiple-compartment drug container |
6287326, | Aug 02 1999 | ZOLL CIRCULATION, INC | Catheter with coiled multi-lumen heat transfer extension |
6299599, | Feb 19 1999 | ZOLL CIRCULATION, INC | Dual balloon central venous line catheter temperature control system |
6332711, | Feb 02 1998 | HOSOKAWA YOKO CO., LTD. | Gusseted bag for medicinal or medical purposes formed of a plastic film laminate composed of a plurality of layers |
6355215, | Mar 10 1999 | ZIMMER TRABECULAR METAL TECHNOLOGY, INC | Wear-resistant olefinic medical implant and thermal treatment container therefor |
6363890, | Mar 06 1998 | DIAMOND STAR PRODUCTS, INC | Package for animal bedding pads |
6368304, | Feb 19 1999 | ZOLL CIRCULATION, INC | Central venous catheter with heat exchange membrane |
6372814, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non-oxidizing polymeric medical implant |
6393320, | Feb 19 1999 | ZOLL CIRCULATION, INC | Method for treating cardiac arrest |
6419643, | Apr 21 1998 | ZOLL CIRCULATION, INC | Central venous catheter with heat exchange properties |
6447474, | Sep 15 1999 | ZOLL CIRCULATION, INC | Automatic fever abatement system |
6450990, | Aug 13 1998 | ZOLL CIRCULATION, INC | Catheter with multiple heating/cooling fibers employing fiber spreading features |
6458150, | Feb 19 1999 | ZOLL CIRCULATION, INC | Method and apparatus for patient temperature control |
6458398, | Oct 18 1999 | TOLAND, ROGER T | Cold water disinfection of foods |
6468377, | May 13 1996 | B. Braun Medical Inc. | Flexible medical container with selectively enlargeable compartments and method for making same |
6516224, | Feb 19 1999 | ZOLL CIRCULATION, INC | Method for treating cardiac arrest |
6572640, | Nov 21 2001 | ZOLL CIRCULATION, INC | Method and apparatus for cardiopulmonary bypass patient temperature control |
6582398, | Feb 19 1999 | ZOLL CIRCULATION, INC | Method of managing patient temperature with a heat exchange catheter |
6589271, | Apr 21 1998 | ZOLL CIRCULATION, INC | Indwelling heat exchange catheter |
6620131, | Feb 19 1999 | ZOLL CIRCULATION, INC | Dual balloon central venous line catheter temperature control system |
6652565, | Apr 21 1998 | ZOLL CIRCULATION, INC | Central venous catheter with heat exchange properties |
6664308, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non-oxidizing polymeric medical implant |
6705061, | Aug 27 1998 | Becton, Dickinson and Company | Method for external decontamination of a packaged object |
6716236, | Apr 21 1998 | ZOLL CIRCULATION, INC | Intravascular catheter with heat exchange element having inner inflation element and methods of use |
6764567, | May 13 1996 | B. Braun Medical | Flexible medical container with selectively enlargeable compartments and method for making same |
6800670, | Jul 09 1996 | Orthopaedic Hospital; University of Southern California | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
6818020, | Jun 01 1993 | HOWMEDICA OSTEONICS CORP | Non-oxidizing polymeric medical implant |
6846305, | May 13 1996 | B BRAUN MEDICAL INC | Flexible multi-compartment container with peelable seals and method for making same |
6849224, | Apr 21 1999 | Howmedica Osteonics Corp. | Methods for preparing selectively cross-linked polyethylene orthopedic devices |
6996951, | May 13 1996 | B. Braun Medical Inc. | Flexible multi-compartment container with peelable seals and method for making same |
6996952, | Sep 30 2003 | Codman & Shurtleff, Inc.; Codman & Shurtleff, Inc | Method for improving stability and effectivity of a drug-device combination product |
7040485, | Sep 30 2003 | Codman & Shurtleff, Inc. | Method and apparatus for packaging a drug-device combination product |
7150853, | Nov 01 2001 | Advanced Cardiovascular Systems, Inc. | Method of sterilizing a medical device |
7263814, | Jun 18 2003 | Oxyband Technologies, Inc. | Method and apparatus for supplying gas to an area |
7275640, | Feb 05 2004 | Boston Scientific Scimed, Inc | Packaging for imparting anti-microbial properties to a medical device |
7278984, | Dec 31 2002 | ZOLL CIRCULATION, INC | System and method for controlling rate of heat exchange with patient |
7297384, | Dec 07 2004 | Metallized heat resistant material with thermal barrier | |
7517919, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
7631760, | Feb 07 2008 | AMCOR FLEXIBLES HEALTHCARE, INC | Dual compartment pouch |
7641632, | Dec 31 2002 | ZOLL CIRCULATION, INC | System and method for controlling rate of heat exchange with patient |
7695674, | Sep 29 2003 | Medtronic Vascular, Inc | Method of sterilizing balloon with ionizing radiation |
7714036, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
7762044, | Jan 27 2003 | Medtronic Vascular, Inc | Packaging for stent delivery systems |
7858671, | Feb 13 1996 | The General Hospital Corporation; Massachusetts Institute of Technology | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
8003709, | Jul 09 1996 | Orthopaedic Hospital | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
8008365, | Jul 09 1996 | Orthopaedic Hospital | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
8030370, | Jun 06 2002 | How medica Osteonics Corp. | Sequentially cross-linked polyethylene |
8124127, | Oct 15 2005 | ATRIUM MEDICAL CORPORATION | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
8128595, | Apr 21 1998 | ZOLL CIRCULATION, INC | Method for a central venous line catheter having a temperature control system |
8211362, | Sep 24 2003 | Nipro Corporation | Packaged blood purification device |
8231003, | Jan 26 2007 | Sartorius Stedim Biotech GmbH | Protected filter units for safety filtration and method for production thereof |
8263102, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Drug delivery coating for use with a stent |
8263676, | Feb 13 1996 | The General Hospital Corporation; Massachusetts Institute of Technology | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
8297439, | Jan 27 2003 | Medtronic Vascular, Inc. | Packaging for a stent delivery system |
8312836, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Method and apparatus for application of a fresh coating on a medical device |
8324291, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
8367099, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Perforated fatty acid films |
8387347, | Jan 21 2005 | Terumo Kabushiki Kaisha | Process for producing and sterilizing a catheter |
8449520, | Mar 19 2007 | HEMCON LIFE SCIENCES, INC | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
8501229, | Oct 15 2005 | ATRIUM MEDICAL CORPORATION | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
8563623, | Oct 02 1996 | The General Hospital Corporation; Massachusetts Institute of Technology | Radiation melt treated ultra high molecular weight polyethylene prosthetic devices |
8574618, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Perforated bioabsorbable oil film and methods for making the same |
8574627, | Nov 06 2006 | ATRIUM MEDICAL CORPORATION | Coated surgical mesh |
8680173, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
8722077, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Drug delivery coating for use with a stent |
8747738, | Aug 15 2006 | ABBOTT CARDIOVASCULAR SYSTEMS INC | Sterilization methods for medical devices |
8795703, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Stand-alone film and methods for making the same |
8858978, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Heat cured gel and method of making |
8865788, | Feb 13 1996 | CENTERPULSE ORTHOPEDICS INC | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
8962023, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | UV cured gel and method of making |
8968648, | May 16 2008 | Terumo Kabushiki Kaisha | Method for radiation sterilization of hydrophilic polymer-coated medical device |
9000040, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
9012506, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
9050410, | Oct 15 2004 | Nipro Corporation | Blood purifier and blood purifier package |
9056280, | Oct 15 2004 | Nipro Corporation | Method for sterilizing blood purifier and blood purifier package |
9067178, | Dec 22 2004 | Nipro Corporation | Blood purifier package and process for manufacturing the same |
9181409, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
9220820, | Oct 15 2005 | ATRIUM MEDICAL CORPORATION | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
9253987, | Jan 22 2010 | Hyprotek, Inc. | Antimicrobial agents and methods of use |
9278161, | Sep 28 2005 | ATRIUM MEDICAL CORPORATION | Tissue-separating fatty acid adhesion barrier |
9364588, | Feb 04 2014 | ABBOTT CARDIOVASCULAR SYSTEMS INC | Drug delivery scaffold or stent with a novolimus and lactide based coating such that novolimus has a minimum amount of bonding to the coating |
9414893, | May 24 2013 | Protective box for surgery | |
9427423, | Mar 10 2009 | ATRIUM MEDICAL CORPORATION | Fatty-acid based particles |
9492596, | Nov 06 2006 | ATRIUM MEDICAL CORPORATION | Barrier layer with underlying medical device and one or more reinforcing support structures |
9504782, | Sep 04 2006 | Roche Diabetes Care, Inc | Package for hydrophilic medical instruments |
9545487, | Apr 13 2012 | Boehringer Ingelheim International GmbH | Dispenser with encoding means |
9561893, | Dec 05 2013 | TELEFLEX LIFE SCIENCES LLC | System and method for freeze-drying and packaging |
9592324, | Nov 06 2006 | ATRIUM MEDICAL CORPORATION | Tissue separating device with reinforced support for anchoring mechanisms |
9649436, | Sep 21 2011 | Bayer HealthCare LLC | Assembly method for a fluid pump device for a continuous multi-fluid delivery system |
9650476, | Jun 06 2002 | Howmedica Osteonics Corp. | Sequentially cross-linked polyethylene |
9682162, | Aug 15 2006 | Abbott Cardiovascular Systems Inc. | Sterilization methods for medical devices |
9682175, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Coating material and medical device system including same |
9682202, | May 18 2009 | Boehringer Ingelheim International GmbH | Adapter, inhalation device, and atomizer |
9700672, | Sep 21 2011 | Bayer HealthCare LLC | Continuous multi-fluid pump device, drive and actuating system and method |
9724482, | Nov 25 2009 | Boehringer Ingelheim International GmbH | Nebulizer |
9744313, | Aug 09 2013 | Boehringer Ingelheim International GmbH | Nebulizer |
9757750, | Apr 01 2011 | Boehringer Ingelheim International GmbH | Medicinal device with container |
9789005, | Sep 02 2009 | Hyprotek, Inc. | Antimicrobial medical dressings and protecting wounds and catheter sites |
9801913, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Barrier layer |
9801982, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Implantable barrier device |
9827352, | Sep 28 2004 | ATRIUM MEDICAL CORPORATION | Cross-linked fatty acid-based biomaterials |
9827384, | May 23 2011 | Boehringer Ingelheim International GmbH | Nebulizer |
9867880, | Jun 13 2012 | ATRIUM MEDICAL CORPORATION | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
9943654, | Jun 24 2010 | Boehringer Ingelheim International GmbH | Nebulizer |
9987408, | Dec 22 2004 | Nipro Corporation | Blood purifier package and process for manufacturing the same |
9987409, | Oct 15 2004 | Nipro Corporation | Blood purifier and blood purifier package |
Patent | Priority | Assignee | Title |
2746193, | |||
3618283, | |||
3726057, | |||
3815315, | |||
3850084, | |||
4022324, | Apr 10 1975 | Sealed container for storing medical and/or bio-medical articles in sterile condition and having removable cover | |
4035981, | Dec 05 1975 | Alcan Research and Development Limited | Aseptic packaging |
4223512, | Nov 29 1977 | Robert Bosch GmbH | Method of packaging and sterilizing products |
4603538, | Nov 15 1984 | Technology Holding Company II | Method of preparing a double sterile package |
JP58134840, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 01 1987 | Nissho Corporation | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Sep 08 1992 | M183: Payment of Maintenance Fee, 4th Year, Large Entity. |
Sep 11 1996 | M184: Payment of Maintenance Fee, 8th Year, Large Entity. |
Feb 27 1997 | ASPN: Payor Number Assigned. |
Sep 12 2000 | M185: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Mar 21 1992 | 4 years fee payment window open |
Sep 21 1992 | 6 months grace period start (w surcharge) |
Mar 21 1993 | patent expiry (for year 4) |
Mar 21 1995 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 21 1996 | 8 years fee payment window open |
Sep 21 1996 | 6 months grace period start (w surcharge) |
Mar 21 1997 | patent expiry (for year 8) |
Mar 21 1999 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 21 2000 | 12 years fee payment window open |
Sep 21 2000 | 6 months grace period start (w surcharge) |
Mar 21 2001 | patent expiry (for year 12) |
Mar 21 2003 | 2 years to revive unintentionally abandoned end. (for year 12) |